neparvis
novartis europharm limited - sacubitril, valsartan - hjertefejl - agenter, der virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
enalapril/hydrochlorothiazide "mylan" 20+12,5 mg tabletter
mylan ab - enalaprilmaleat, hydrochlorthiazid - tabletter - 20+12,5 mg
enalapril/hydrochlorothiazide "orion" 20+12,5 mg tabletter
orion corporation - enalaprilmaleat, hydrochlorthiazid - tabletter - 20+12,5 mg
valhelen 160 mg filmovertrukne tabletter
krka sverige ab - valsartan - filmovertrukne tabletter - 160 mg
valhelen 80 mg filmovertrukne tabletter
krka sverige ab - valsartan - filmovertrukne tabletter - 80 mg
salarvant 160 mg kapsler, hårde
mylan ab - valsartan - kapsler, hårde - 160 mg
salarvant 40 mg kapsler, hårde
mylan ab - valsartan - kapsler, hårde - 40 mg
salarvant 80 mg kapsler, hårde
mylan ab - valsartan - kapsler, hårde - 80 mg
valhelen 40 mg filmovertrukne tabletter
krka sverige ab - valsartan - filmovertrukne tabletter - 40 mg
daratekan 160 mg filmovertrukne tabletter
2care4 aps - valsartan - filmovertrukne tabletter - 160 mg